medigraphic.com
Colegio de Medicina Interna de México.

2020, Number S4

<< Back Next >>

Med Int Mex 2020; 36 (S4)

Carbohydrates

Hernández-Téllez G

Language: Spanish
References: 19
Page: 18-20
PDF size: 290.28 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Qiao S, et al. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: A Two-Center. Retrospective Study. Diabetes Care 2020. dc200598. doi. 10.2337/dc20-0598

  2. Guan W. Shan clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-20. doi. 10.1056/NEJMoa2002032

  3. Yang JK, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006; 23: 623e8. https://doi. org/10.1111/j.1464-5491.2006.01861.x

  4. Pal R, et al. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes & Metabolic Syndrome. Clin Res Rev. 2020; 14: 513-17. https://doi. org/10.1016/j.dsx.2020.04.049

  5. Perez A, et al. Glucocorticoid-induced hyperglycemia. J Diabetes 2014; 6 (1): 9-20. https://doi.org/10.1111/1753- 0407.12090

  6. Wondafrash DZ, et al. Potential effect of hydroxychloroquine in diabetes mellitus: A Systematic Review on Preclinical and Clinical Trial Studies. J Diabetes Res. 2020;2020:5214751. https://doi.org/10.1155/2020/5214751

  7. Gautret P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 105949. https://doi.org/10.1016/j.ijantimicag.2020.105949

  8. Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev. 2020; 21 (6): e13034. https://doi.org/10.1111/obr.13034

  9. Barazzoni R, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020; 39: 1631-38. https:// doi.org/10.1016/j.clnu.2020.03.022

  10. Bermúdez Ch, et al. Recomendaciones nutricionales de la Asociación Colombiana de Nutrición Clínica para pacientes hospitalizados con infección por SARS-CoV-2 Rev Nutr Clin Metab. 2020; 3 (1). https://doi.org/10.35454/rncm. v3n1.066

  11. Baró-Moral S, Fernández-López J. Inmunonutrición. Recomendaciones de alimentación y nutrición frente al COVID-19. Revisión bibliográfica. 07 Seminarios de iniciación a la investigacción en Ciencias Avanzadas de la Nutrición. Abril 2020.

  12. Fussell ST. Enteral nutrition: A comprehensive overview. In: Matarese L.E. and Gottschlich M.M. (eds.), Contemporary Nutrition Support Practice: A Clinical Guide. 2nd ed. Philadelphia: WB Saunders, 2003; 188-200.

  13. Peters AL, Davidson MB. Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. J Parent Ent Nutr. 1992; 16: 69-74.

  14. Ioannis Zabetakis, et al. COVID-19: The inflammation link and the role of nutrition in potential mitigation nutrients 2020; 12, 1466. doi.10.3390/nu12051466

  15. Lobo-Tamer G, et al. Dietas específicas en nutrición enteral. Análisis de la evidencia. Nutr Clin Med. 2016; X (3): 123-39.

  16. Reshmi Srinatha, et al. Dietary management of blood glucose in medical critically ill patients with overweight/ obesity. Curr Opin Clin Nutr Metab Care 2020; 23: 116-20.

  17. Schley PD, Field CJ. The immune-enhancing effects of dietary fibers and prebiotics. Br J Nutr. 2002; 87 (Suppl. 2): S221- S230. https://doi.org/10.1079/BJN/2002541

  18. Gou W, et al. Gut microbiota may underlie the predisposition of healthy individuals to COVID-19. medRxiv 2020. doi: https://doi.org/10.1101/2020.04.22.20076091.

  19. Dhar D. Gut microbiota and COVID19- possible link and implications. Virus Res. 2020 Aug; 285: 198018. 10.1016/j. virusres.2020.198018




2020     |     www.medigraphic.com